Het onderzoeken van axonale transport defecten in de ziekte van Charcot-Marie-Tooth type 1 en modificatie hiervan via selectieve inhibitie van histone deacetylase 6
De rol van histone deacetylase 6 (HDAC6) bij perifere axonale neuropathieën en amyotrofische laterale sclerose (ALS)
Investigation of selective inhibition of histone deacetylase 6 as a therapeutic strategy for Charcot Marie-Tooth disease type 1A
Rol van histon deacetylase 6 (HDAC6) biji perifere axonale neuropathieën en bij amyotrofische laterale sclerose (ALS).
Tetrahydroquinoline-Capped Histone Deacetylase 6 Inhibitor SW-101 Ameliorates Pathological Phenotypes in a Charcot-Marie-Tooth Type 2A Mouse Model.
Inhibition of histone deacetylase 6 (HDAC6) protects against vincristine-induced peripheral neuropathies and inhibits tumor growth
Bicyclic-Capped Histone Deacetylase 6 Inhibitors with Improved Activity in a Model of Axonal Charcot-Marie-Tooth Disease
Brain Penetrable Histone Deacetylase 6 Inhibitor SW-100 Ameliorates Memory and Learning Impairments in a Mouse Model of Fragile X Syndrome